These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 37830930)
21. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression. Mushi MF; Olum R; Bongomin F Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514 [TBL] [Abstract][Full Text] [Related]
22. Antifungal effect of hydroethanolic extract of Fridericia chica (Bonpl.) L. G. Lohmann leaves and its therapeutic use in a vulvovaginal candidosis model. Lima WG; Araújo MGF; Brito JCM; Castilho RO; Cardoso VN; Fernandes SOA J Mycol Med; 2022 Aug; 32(3):101255. PubMed ID: 35219909 [TBL] [Abstract][Full Text] [Related]
23. In vitro outcomes of quercetin on Candida albicans planktonic and biofilm cells and in vivo effects on vulvovaginal candidiasis. Evidences of its mechanisms of action. Tan Y; Lin Q; Yao J; Zhang G; Peng X; Tian J Phytomedicine; 2023 Jun; 114():154800. PubMed ID: 37043980 [TBL] [Abstract][Full Text] [Related]
24. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age. Khan F; Baqai R J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297 [TBL] [Abstract][Full Text] [Related]
25. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis. de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209 [TBL] [Abstract][Full Text] [Related]
27. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats. Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301 [TBL] [Abstract][Full Text] [Related]
28. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. Bitew A; Abebaw Y BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998 [TBL] [Abstract][Full Text] [Related]
29. Miconazole for the treatment of vulvovaginal candidiasis. Regidor PA; Thamkhantho M; Chayachinda C; Palacios S J Obstet Gynaecol; 2023 Dec; 43(1):2195001. PubMed ID: 37029724 [TBL] [Abstract][Full Text] [Related]
30. The liquid Kangfuxin (KFX) has efficient antifungal activity and can be used in the treatment of vulvovaginal candidiasis in mice. Ma J; Yang YC; Su LQ; Qin DM; Yuan K; Zhang Y; Wang RR Lett Appl Microbiol; 2022 Apr; 74(4):564-576. PubMed ID: 34958703 [TBL] [Abstract][Full Text] [Related]
31. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment. de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916 [TBL] [Abstract][Full Text] [Related]
32. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis. Zhu Y; Shan Y; Fan S; Li J; Liu X Mycopathologia; 2015 Feb; 179(1-2):111-8. PubMed ID: 25322705 [TBL] [Abstract][Full Text] [Related]
33. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study. Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795 [TBL] [Abstract][Full Text] [Related]
34. Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis. Liao H; Liu S; Wang H; Su H; Liu Z BMC Microbiol; 2019 Jan; 19(1):7. PubMed ID: 30621597 [TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. Fan SR; Liu XP; Li JW J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710 [TBL] [Abstract][Full Text] [Related]
36. Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern. Fernandes Â; Azevedo N; Valente A; Dias M; Gomes A; Nogueira-Silva C; Henriques M; Silva S; Gonçalves B Med Mycol; 2022 May; 60(5):. PubMed ID: 35482711 [TBL] [Abstract][Full Text] [Related]
37. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis. Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431 [TBL] [Abstract][Full Text] [Related]
39. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis. Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810 [TBL] [Abstract][Full Text] [Related]
40. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. Liu XP; Fan SR; Peng YT; Zhang HP J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]